https://www.pharmacompass.com/radio-compass-blog/divi-s-labs-on-fda-s-import-alert-list-but-did-it-refuse-an-inspection
02 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/02/2957347/0/en/Processa-Pharmaceuticals-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-NGC-Cap-in-Metastatic-Breast-Cancer.html
08 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/oral-report--the-positive-interim-analysis-results-from-the-phase-iii-clinical-study-of-akesos--cadonilimab-pd-1ctla-4-bsab-plus-chemotherapy-as-first-line-treatment-for-advanced-gastric-cancer-presented-at-2024-aacr-302110917.html
19 Dec 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/12/19/2798574/0/en/Processa-Pharmaceuticals-Provides-Interim-Analysis-from-Ongoing-Phase-1b-Trial-of-Next-Generation-Capecitabine-Showing-Improved-Safety-Over-Capecitabine.html
08 Nov 2023
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/akeso-claims-overall-survival-win-its-bispecific-patients-severe-gastric-cancer
12 Oct 2023
// BUSINESSWIRE
30 Aug 2023
// ONCLIVE
https://www.onclive.com/view/trifluridine-tipiracil-plus-bevacizumab-provides-potential-first-line-alternative-to-bevacizumab-capecitabine-in-mcrc
LOOKING FOR A SUPPLIER?